Cargando…
Cell cloning-based transcriptome analysis in Rett patients: relevance to the pathogenesis of Rett syndrome of new human MeCP2 target genes
More than 90% of Rett syndrome (RTT) patients have heterozygous mutations in the X-linked methyl-CpG binding protein 2 (MECP2) gene that encodes the methyl-CpG-binding protein 2, a transcriptional modulator. Because MECP2 is subjected to X chromosome inactivation (XCI), girls with RTT either express...
Autores principales: | Nectoux, J, Fichou, Y, Rosas-Vargas, H, Cagnard, N, Bahi-Buisson, N, Nusbaum, P, Letourneur, F, Chelly, J, Bienvenu, T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823278/ https://www.ncbi.nlm.nih.gov/pubmed/20569274 http://dx.doi.org/10.1111/j.1582-4934.2010.01107.x |
Ejemplares similares
-
MeCP2 Deficiency in Neuroglia: New Progress in the Pathogenesis of Rett Syndrome
por: Jin, Xu-Rui, et al.
Publicado: (2017) -
Structural investigation of Rett-inducing MeCP2 mutations()
por: Spiga, Ottavia, et al.
Publicado: (2018) -
Rett mutations attenuate phase separation of MeCP2
por: Fan, Chunyan, et al.
Publicado: (2020) -
The Molecular Functions of MeCP2 in Rett Syndrome Pathology
por: Sharifi, Osman, et al.
Publicado: (2021) -
MeCP2: The Genetic Driver of Rett Syndrome Epigenetics
por: Good, Katrina V., et al.
Publicado: (2021)